BioHarvest Sciences Inc.

8MV0.F

1.41 EUR

1 Tag: -8.44% (-0.13 EUR)

Der Alarm wird direkt gespeichert, ohne auf die Homepage zu springen.

Kursalarme fuer 8MV0.F

Bitte anmelden, um Kursalarme zu sehen und zu speichern.

Finanzen

Umsatz35.48 Mio. EUR
EBITDA-5.80 Mio. EUR
Nettogewinn-11.07 Mio. EUR
Market Cap31.96 Mio. EUR
KGVN/A
Div. RenditeN/A
52W Hoch10.80 EUR
52W Tief1.41 EUR

Kurschart

Chart wird geladen...
Unternehmensinfo

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules. The company is based in Vancouver, Canada.

Aktuelle News